Rania Abdellatif

1.2k total citations
26 papers, 526 citations indexed

About

Rania Abdellatif is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Rania Abdellatif has authored 26 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Rania Abdellatif's work include Liver Disease and Transplantation (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Rania Abdellatif is often cited by papers focused on Liver Disease and Transplantation (4 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Rania Abdellatif collaborates with scholars based in Egypt, Qatar and Saudi Arabia. Rania Abdellatif's co-authors include Rehab Ahmed Rifaai, Entesar F. Amin, Gehan H. Heeba, Mohamed A. Morsy, Soha Osama Hassanin, Katharigatta N. Venugopala, Anroop B. Nair, Tamer M. Shehata, Heba S. Elsewedy and Ashraf Taye and has published in prestigious journals such as Journal of the American College of Cardiology, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Rania Abdellatif

22 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rania Abdellatif Egypt 13 135 128 72 61 58 26 526
Mohamed K. El-Kherbetawy Egypt 16 196 1.5× 77 0.6× 64 0.9× 13 0.2× 67 1.2× 36 609
Amir Ghorbani Haghjo Iran 12 157 1.2× 151 1.2× 66 0.9× 9 0.1× 49 0.8× 17 532
Davoud Sanajou Iran 16 242 1.8× 167 1.3× 87 1.2× 9 0.1× 87 1.5× 26 740
May Abu‐Taha Jordan 8 192 1.4× 85 0.7× 31 0.4× 8 0.1× 50 0.9× 12 610
Wakana Goto Japan 12 241 1.8× 61 0.5× 43 0.6× 18 0.3× 15 0.3× 20 607
Junguo Duan China 11 205 1.5× 33 0.3× 22 0.3× 13 0.2× 37 0.6× 27 483
Noha M. Abogresha Egypt 12 111 0.8× 38 0.3× 55 0.8× 13 0.2× 74 1.3× 17 366
Michael Deeds United States 6 245 1.8× 223 1.7× 218 3.0× 12 0.2× 15 0.3× 14 668
Mohamed El‐Gamal Egypt 9 91 0.7× 77 0.6× 36 0.5× 9 0.1× 14 0.2× 17 431

Countries citing papers authored by Rania Abdellatif

Since Specialization
Citations

This map shows the geographic impact of Rania Abdellatif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rania Abdellatif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rania Abdellatif more than expected).

Fields of papers citing papers by Rania Abdellatif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rania Abdellatif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rania Abdellatif. The network helps show where Rania Abdellatif may publish in the future.

Co-authorship network of co-authors of Rania Abdellatif

This figure shows the co-authorship network connecting the top 25 collaborators of Rania Abdellatif. A scholar is included among the top collaborators of Rania Abdellatif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rania Abdellatif. Rania Abdellatif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Abushanab, Dina, Shereen Mohamed, Rania Abdellatif, et al.. (2025). Dihydropyrimidine Dehydrogenase Deficiency (DPYD) Genotyping-Guided Fluoropyrimidine-Based Adjuvant Chemotherapy for Breast Cancer. A Cost-Effectiveness Analysis. Clinical Drug Investigation. 45(3). 151–163. 1 indexed citations
3.
Abushanab, Dina, Rania Abdellatif, Wadha Al‐Muftah, et al.. (2024). Cost-effectiveness analysis of genotype-guided optimization of major depression treatment in Qatar. Journal of Pharmaceutical Policy and Practice. 17(1). 2410197–2410197. 2 indexed citations
4.
Abdellatif, Rania, Radja Badji, Wadha Al‐Muftah, et al.. (2024). QPGx‐CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies. Clinical and Translational Science. 17(6). e13800–e13800. 4 indexed citations
5.
Morsy, Mohamed A., et al.. (2024). Calcitriol ameliorates cisplatin-induced hepatorenal toxicity via regulation of Nrf2-Mrp2/p38 MAPK signaling in mice. International Journal of Immunopathology and Pharmacology. 38. 1210526372–1210526372.
6.
Gavanji, Shahin, Azizollah Bakhtari, Rania Abdellatif, Elena Bencúrová, & Eman M. Othman. (2024). Experimental approaches for induction of diabetes mellitus and assessment of antidiabetic activity: An in vitro and in vivo methodological review. Fundamental and Clinical Pharmacology. 38(5). 842–861. 1 indexed citations
7.
Abdellatif, Rania, et al.. (2023). Ghrelin hormone a new molecular modulator between obesity and glomerular damage. Molecular Biology Reports. 50(12). 10525–10533. 3 indexed citations
8.
Abdellatif, Rania, et al.. (2022). Cisplatin-Induced Reproductive Toxicity and Oxidative Stress: Ameliorative Effect of Kinetin. Antioxidants. 11(5). 863–863. 28 indexed citations
9.
Abushanab, Dina, Rania Abdellatif, Ayman El‐Menyar, et al.. (2022). TCTAP A-069 Cost-Effectiveness Analysis of High-Potency Versus Low-Potency Statins for Reducing Mortality in Coronary Artery Disease Patients on Dual Antiplatelet Therapy Post Percutaneous Coronary Intervention.. Journal of the American College of Cardiology. 79(15). S44–S44. 1 indexed citations
10.
Abdellatif, Rania, et al.. (2022). TLRs-JNK/ NF-κB Pathway Underlies the Protective Effect of the Sulfide Salt Against Liver Toxicity. Frontiers in Pharmacology. 13. 850066–850066. 35 indexed citations
11.
Morsy, Mohamed A., Rania Abdellatif, Sara Mohamed Naguib Abdel Hafez, Mahmoud Kandeel, & Seham A. Abdel-Gaber. (2022). Paeonol Protects against Methotrexate Hepatotoxicity by Repressing Oxidative Stress, Inflammation, and Apoptosis—The Role of Drug Efflux Transporters. Pharmaceuticals. 15(10). 1296–1296. 14 indexed citations
12.
Abdellatif, Rania, et al.. (2020). Low-dose lixisenatide protects against early-onset nephropathy induced in diabetic rats. Life Sciences. 263. 118592–118592. 17 indexed citations
13.
14.
Abdellatif, Rania, Rehab Ahmed Rifaai, & Entesar F. Amin. (2020). Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway. Archives of Pharmacal Research. 43(5). 514–525. 71 indexed citations
15.
Morsy, Mohamed A., Rania Abdellatif, Anroop B. Nair, et al.. (2019). Preparation and Evaluation of Atorvastatin-Loaded Nanoemulgel on Wound-Healing Efficacy. Pharmaceutics. 11(11). 609–609. 95 indexed citations
16.
Heeba, Gehan H., et al.. (2019). Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high‐fat diet‐induced nonalcoholic fatty liver in rats. Fundamental and Clinical Pharmacology. 34(3). 353–364. 8 indexed citations
17.
El‐Sheikh, Azza A. K., Mohamed A. Morsy, & Rania Abdellatif. (2019). Modulation of eNOS/iNOS by nebivolol protects against cyclosporine A-mediated nephrotoxicity through targeting inflammatory and apoptotic pathways. Environmental Toxicology and Pharmacology. 69. 26–35. 19 indexed citations
18.
Abdellatif, Rania, Gehan H. Heeba, Ashraf Taye, & Mohamed Mansour Khalifa. (2018). Lixisenatide ameliorates cerebral ischemia-reperfusion injury via GLP-1 receptor dependent/independent pathways. European Journal of Pharmacology. 833. 145–154. 19 indexed citations
19.
Abdellatif, Rania, Gehan H. Heeba, Ashraf Taye, & Mohamed M. Khalifa. (2018). Lixisenatide, a novel GLP-1 analog, protects against cerebral ischemia/reperfusion injury in diabetic rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(7). 705–717. 33 indexed citations
20.
Abdellatif, Rania, Mohamed A. Morsy, Mohamed A. El‐Moselhy, & Mohamed Ali Khalifa. (2013). Sildenafil protects against nitric oxide deficiency-related nephrotoxicity in cyclosporine A treated rats. European Journal of Pharmacology. 705(1-3). 126–134. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed K. El-Kherbetawy Breakdown of academic impact, for papers by Amir Ghorbani Haghjo Breakdown of academic impact, for papers by Davoud Sanajou Breakdown of academic impact, for papers by May Abu‐Taha Breakdown of academic impact, for papers by Wakana Goto Breakdown of academic impact, for papers by Junguo Duan Breakdown of academic impact, for papers by Noha M. Abogresha Breakdown of academic impact, for papers by Michael Deeds Breakdown of academic impact, for papers by Mohamed El‐Gamal
Rankless by CCL
2026